Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$24,127,735
+$6,652,105 QoQ
Shares Held
20,116
+5.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.32%
of 13F equity value
Holder Rank
#820
of 4,605 holders
Holding Since
Mar 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Eversept Partners, LP holds $59,814,180 across 4 Drug Manufacturers - General names. LLY ranks #2 (40.3% of the industry book) .
All Filings in LLY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,127,735 | 20,116 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $17,475,630 | 19,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,416,326 | 10,623 | Shares | Sole | 2026-02-17 | |
| 2024-06-30 | $19,223,933 | 21,233 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,017,790 | 12,877 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||